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As many as 30% of American adults self-report
food allergy and alter their eating habits accord-
ingly (Sloan and Powers 1986). Similarly,
nearly one-third of parents perceive adverse
food reactions to be responsible for a multitude
of symptoms in their children and modify their
children’s diets in response (Bock 1987).
Although accurate and recent epidemiologic
data are scarce, current estimates of the preva-
lence of food allergy suggest that approximately
5% of young children and 1–2% of adults have
reproducible symptoms resulting from food
allergy (Bock 1987; Niestijl et al. 1994).
Despite greater awareness and recognition of
food allergy by both physicians and patients,
many allergists believe that the actual preva-
lence has risen substantially over the past
decade, similar to the rise in prevalence of other
atopic conditions such as asthma and allergic
rhinitis (Ninan and Russell 1992; Peat et al.
1994; Sears 1996).
An adverse reaction to food refers to any
abnormal reaction after the ingestion of food
or food additives. Adverse reactions to foods
may result from enzyme deficiencies such as
lactose intolerance, exaggerated pharmaco-
logic responses to natural or added chemical
agents such as vasoactive amines in wines, or
immunologic responses. Immunologic
responses to foods can be further defined
mechanistically as immunoglobulin (Ig) E
mediated and non-IgE mediated. The best-
characterized adverse reactions to food are
those that are Type I hypersensitivity reac-
tions, i.e., IgE mediated. The spectrum of
food allergy ranges from cutaneous symp-
toms, such as atopic dermatitis, appearing
several hours after the ingestion of the
responsible food to potentially life-threaten-
ing symptoms occurring immediately upon
ingestion. Additionally, some individuals
experience allergic symptoms only if the food
is eaten before specific physical stimuli (for
example, vigorous exercise) or if the individ-
ual has concomitant seasonal allergies,
whereby certain foods elicit oral symptoms,
such as pruritis and local swelling upon inges-
tion. This article is limited to classic type I
hypersensitivity allergic reactions to foods.
Diagnosis
The diagnosis of food allergy rests with the
detection of food-specific IgE and a history
compatible with IgE-mediated symptoms
occurring within an acceptable time frame
(usually < 1 hr) after the isolated ingestion of
the food in question. Symptoms that result
from IgE-mediated mast cell degranulation
products include flushing, urticaria, stridor
or wheeze, and gastrointestinal symptoms
such as abdominal pain or vomiting.
Detection of food-specific IgE can be mea-
sured either with a skin prick test or, in vitro,
with food-specific IgE. Skin prick tests are
inexpensive, simple tests and can be per-
formed in individuals of all ages. Skin prick
tests have excellent sensitivity and negative
predictive value, but variable specificity and
positive predictive values; therefore skin tests,
particularly when performed with fresh
foods, can reliably exclude food allergies
when negative, but cannot confirm food
allergy when positive (Bock et al. 1978; May
1976; Sampson 1988). When measured with
the ImmunoCAP method (Pharmacia &
Upjohn Diagnostics AB, Uppsala, Sweden),
a ﬂuoroenzymatic immunoassay, quantitative
measures of food-specific IgE can be deter-
mined, and these measurements can be use-
ful in the diagnosis of food allergy. The
positive and negative predictive values of a
limited number of food-speciﬁc IgE determi-
nations have been published that deﬁne cut-
off values that reliably predict the likelihood
of food allergy when compared with double-
blind, placebo-controlled, food challenges
(DBPCFC) (Sampson 2001). The DBPCFC
is the “gold standard” of food allergy diagno-
sis and requires the administration of incre-
mental quantities of the suspected food to
the patient in a controlled, blinded, and
supervised setting, where observation and
documentation of objective allergic signs are
noted. The procedure and safety of
DBPCFC have been described elsewhere
(Bock et al. 1988). Thus, the diagnosis of
food allergy can be made when the history is
convincing of an IgE-mediated reaction and
conﬁrmatory skin tests or speciﬁc IgE assays
are positive. However, when the history
elicited is not clearly typical of an IgE-medi-
ated reaction, either by description of symp-
toms or in timing, or when the meal that
produced the reaction contained several aller-
gic possibilities, positive skin tests or speciﬁc
IgE measurements must be confirmed with
DBPCFC before an accurate diagnosis of
food allergy is made. Clearly, when the his-
tory and lab tests are convincing of food
allergy, the DBPCFC is not indicated.
Natural History of Food Allergy
Most food allergies have their onset in
infancy or early childhood, depending on
when the food is introduced into the diet.
Theoretically, any food containing a protein
could elicit an allergic reaction; however,
eight common foods are responsible for
> 90% of food allergies (Hefle et al. 1996).
The natural history of food allergy varies with
the individual food, but many of the foods
that elicit allergic reactions in young children
can be eventually reintroduced into the diet.
Thus, most food allergies can be classiﬁed as
“likely to resolve” or “likely to persist.” Food
allergies that usually resolve include milk, soy,
egg, and wheat. These allergies typically pre-
sent in infancy and usually resolve by school
age. Food allergies that usually persist include
peanut, tree nuts, fish, and shellfish. These,
too, usually present in early childhood, shortly
after the introduction of these foods into the
usual diet. Although most individuals with
Address correspondence to R. Kagan, The Montreal
Children’s Hospital, 2300 Tupper Street, Room
C-510, Montreal, Quebec H3H 1P3 Canada.
Telephone: (514) 412-4470. Fax: (514) 412-4390.
E-mail: rhoda.kagan@muhc.mcgill.ca
This article is part of the mini-monograph
“Animal Models to Detect Allergenicity to Foods
and Genetically Modiﬁed Products.”
Received 9 April 2002; accepted 2 October 2002.
Food allergy affects between 5% and 7.5% of children and between 1% and 2% of adults. The
greater prevalence of food allergy in children reﬂects both the increased predisposition of children
to develop food allergies and the development of immunologic tolerance to certain foods over
time. Immunoglobulin (Ig) E-mediated food allergies can be classiﬁed as those that persist indeﬁ-
nitely and those that are predominantly transient. Although there is overlap between the two
groups, certain foods are more likely than others to be tolerated in late childhood and adulthood.
The diagnosis of food allergy rests with the detection of food-speciﬁc IgE in the context of a con-
vincing history of type I hypersensitivity-mediated symptoms after ingestion of the suspected food
or by eliciting IgE-mediated symptoms after controlled administration of the suspected food.
Presently, the only available treatment of food allergies is dietary vigilance and administration of
self-injectable epinephrine. Key words: epidemiology, food allergy, IgE-mediated hypersensitivity.
Environ Health Perspect 111:223–225 (2003).
doi:10.1289/ehp.5702 available via http://dx.doi.org/
Allergenicity Models | Mini-Monograph
[Online 21 January 2003]allergies to foods in this latter group tend to
persist with these allergies indeﬁnitely, some
children will develop tolerance to these foods
and will be able to reintroduce them safely
into their diet.
Milk allergy almost always presents in the
ﬁrst year of life, soon after the introduction of
cow’s milk or cow’s milk–based infant formula,
and usually resolves by school age. Most infants
with cow’s milk allergy develop gastrointestinal
symptoms, approximately 50–70% have cuta-
neous features, and about 20–30% will have
respiratory symptoms (Host 1994). Milk
allergy affects up to 2.5% of infants, with
approximately 1% of all children developing
IgE-mediated milk allergy and approximately
1.5% of children developing non-IgE-mediated
milk allergy (Host and Halken 1990). In a
prospective study by Host and Halken (1990),
39 infants in a birth cohort of 1,749 unselected
newborns were diagnosed with cow’s milk pro-
tein allergy/intolerance based on elimination
diets and milk rechallenges. Of 39 infants diag-
nosed with milk allergy or milk intolerance, 21
infants had positive skin or serum IgE tests to
milk and 18 had non-IgE-mediated cow’s milk
intolerance. Of the total group, 56% were able
to tolerate milk by 1 year of age, 77% by 2
years, and 87% by 3 years. Of children with
IgE-mediated cow’s milk allergy, 14% had per-
sistent milk allergy at the age of 5 and 10 years.
All of the children with non-IgE-mediated
cow’s milk allergy and most children with IgE-
mediated cow’s milk allergy were able to rein-
troduce milk products by age 5; however, 3 of
21 of the IgE-mediated group remained allergic
well into mid-childhood. Thus, in an unse-
lected population, milk allergy usually resolves
by school age, but among highly atopic chil-
dren, milk allergy is more likely to persist
(Bishop et al. 1990; Tikkanen et al. 2000).
Risk factors for persistence of milk allergy
include early dermatitis presentation of milk
allergy; development of other atopic condi-
tions, including other food allergies, asthma,
and allergic rhinitis; and persistence of ele-
vated levels of milk-speciﬁc IgE (Sicherer and
Sampson 1999; Zeiger et al. 1999). In gen-
eral, as tolerance to IgE-mediated milk allergy
is achieved, the size of the wheal and ﬂare on
the skin prick tests decreases; however, it may
continue to remain positive beyond acquisi-
tion of clinical tolerance. Serum-speciﬁc IgE,
measured by the ImmunoCAP system,
appears to be a more sensitive measure for the
prediction of food allergy resolution, espe-
cially in patients with atopic dermatitis
(Sampson 2001).
Soy is considered a major food allergen
and is a food introduced to infants in the
form of infant formulas and cereals. Soy-
based infant formulas are recommended
for families following vegetarian dietary
restrictions, for children with congenital or
acquired lactose intolerance, and for infants
with diagnosed IgE-mediated cow’s milk
allergy. Of children with IgE-mediated cow’s
milk allergy, fewer than 15% will develop a
concomitant allergy to soy, but most infants
will tolerate soy protein without difficulty
(Zeiger et al. 1999). The prevalence of soy
allergy/soy intolerance varies with the fre-
quency with which soy is introduced into
regional diets, but it appears to affect 1–6%
of infants (Giampietro et al. 1997; Magnolﬁ
et al. 1996). Symptoms associated with soy
allergy include typical IgE-mediated features
as well as non-IgE-mediated—gastrointestinal
symptoms such as hematochezia and malab-
sorption. Both skin prick tests and food-spe-
cific IgE are used to detect the presence of
IgE; however, both modalities have poor
specificity and positive predictive values
(Giampietro et al. 1997; Sampson 2001).
The natural history of IgE-mediated soy
allergy is similar to that of other “predomi-
nantly transient” allergies, and most children
can tolerate soy products by school age.
The prevalence of egg allergy is estimated
at 1.6–2.6% of the general pediatric popula-
tion but is significantly higher among indi-
viduals with atopic dermatitis and other
collateral atopic conditions (Danneus et al.
1977; Eggesbo et al. 2001). Most children
developing allergic symptoms to ingestion of
egg develop symptoms within 30 min. More
than 85% of egg-allergic children develop
cutaneous symptoms, 60% have gastrointesti-
nal symptoms, and up to 40% will have asso-
ciated respiratory symptoms (Eggesbo et al.
2001; Ford and Taylor 1982). In Ford and
Taylor’s (1982) description of the natural his-
tory of egg allergy, 44% of egg-allergic chil-
dren were able to reintroduce egg products
into their diet by school age, but the remain-
ing 56% persisted with egg allergy. Children
with persistent egg allergy had significantly
more target organs affected at the time of the
initial allergic reaction, were more likely to
acquire additional atopic conditions, and
continued to have positive prick skin tests to
egg. Egg-specific IgE, measured by the
ImmunoCAP method, is useful in predicting
the likelihood of positive challenges, and cut-
off values have been proposed for this effect
(Sampson 2001).
Peanuts, nuts, fish, and seafood allergies
generally persist indefinitely. Other foods,
particularly seeds (e.g., sesame, poppy, mus-
tard), might also be added to this list.
Uncommonly, reports of tolerance develop-
ing to these foods have been published, but
until very recently, the persistence of these
food allergies has been expected.
Peanut allergy deserves particular atten-
tion because it almost always presents early in
life, is often severe, generally persists indefi-
nitely, and is the most common cause of fatal
food-related anaphylaxis (Bock and Atkins
1989; Sampson et al. 1992). Additionally,
because of peanut’s relative ubiquity, acciden-
tal exposures occur frequently, despite vigi-
lant attempts to avoid peanut-containing
foods (Bock and Atkins 1989; Vander Leek et
al. 2000). The prevalence of peanut allergy is
approximately 0.6%, and there is some evi-
dence that this has increased (Grundy et al.
2002; Sampson 1996; Sicherer et al. 1999;
Tariq et al. 1996). Tariq et al. (1996)
described the prevalence of peanut allergy and
peanut sensitization in a birth cohort of chil-
dren born between 1989 and 1990. The
prevalence of sensitization to peanut was
1.1% and the prevalence of conﬁrmed peanut
allergy was 0.5%. In 2001, a similar birth
cohort, born between 1994 and 1996, was
prospectively followed for evidence of peanut
sensitization and allergy. The sensitization
prevalence had increased to 3.2%, and the
peanut allergy prevalence rose to 1.5%
(Grundy et al. 2002).
Approximately 80% of peanut-allergic
children develop allergic symptoms at the
time of their ﬁrst known exposure to peanut,
> 90% develop symptoms within 30 min of
ingestion, 90% have cutaneous features, 40%
have respiratory symptoms, and 50%
develop allergic manifestations to contact
alone (Hourihane et al. 1997; Sicherer et al.
1998). After diagnosis and despite avoidance
measures, most peanut-allergic children have
accidental exposures to peanut resulting in
allergic symptoms, and > 40% of subsequent
allergic reactions may be more severe than
the initial reaction (Bock and Atkins 1989;
Vander Leek et al. 2000). However, in a sub-
set of peanut-allergic children, up to 20%
will become tolerant to peanut and will be
able to reintroduce peanut into their diets
(Hourihane et al. 1998; Skolnick et al. 2001;
Spergel et al. 2000). Factors that appear to
predict resolution of peanut allergy include
mild cutaneous allergic features at onset,
fewer associated atopic features, loss or
diminution of skin prick test reactions to
peanut, and low levels of peanut-speciﬁc IgE.
Studies on the natural history of allergies
to other foods considered to be “lifelong” are
scant. Although it does appear that most
adults with shellﬁsh allergy remain allergic to
crustaceans, reports of individuals becoming
tolerant to shrimp have been published
(Daul et al. 1990). Likewise, it is possible
that tolerance to other “persistent” food
allergies may develop in some individuals,
but publications provide little guidance in
determining which patients may resume eat-
ing these foods. In the interim, patients with
allergies to nuts, seeds, fish, and crustaceans
are advised to avoid ingesting these foods
indefinitely, unless oral challenge tests
demonstrate acquisition of tolerance.
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The treatment of food allergy is limited to
encouraging strict dietary vigilance and the
ability to self-treat an allergic reaction if it
were to occur. Maintaining dietary vigilance
is difficult and stressful but can reduce the
likelihood of experiencing an accidental
ingestion of the allergic food (Bock and
Atkins 1989; Ewan and Clark 2001; Primeau
et al. 2000; Vander Leek et al. 2000).
Currently, the only available therapy for food
allergy is avoidance and self-treatment with
auto-injectable epinephrine. Early adminis-
tration of epinephrine is life-saving, and
proper technique should be taught to all
food-allergic individuals (Sampson et al.
1992). Promising immunotherapy interven-
tions are being developed to diminish the
severity of life-threatening food allergies but
are not yet commercially available.
Conclusion
Food allergies affect between 5% and 8% of
the pediatric population and between 1% and
2% of the adult population and appear to be
rising. Many food allergies are “outgrown”
during childhood, but some individuals never
develop tolerance to some of the more com-
monly seen “transient” food allergens and
remain symptomatic indefinitely. Factors
associated with the persistence of “transient”
food allergies include early onset, greater
severity of allergy expression, collateral atopic
conditions, persistence of skin prick test reac-
tions, and elevated food-specific IgE.
Conversely, a minority of individuals with
allergy to foods traditionally believed to per-
sist indeﬁnitely have demonstrated loss of the
allergy and clinical tolerance. Further research
into the risk factors and associated clinical
and laboratory tests that may predict persis-
tence or resolution of food allergy may help
to characterize this dichotomy.
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